Encision Inc. (ECIA)
OTCMKTS
· Delayed Price · Currency is USD
0.2488
+0.0112 (4.71%)
At close: Nov 18, 2025
Encision Revenue
Encision had revenue of $1.53M in the quarter ending September 30, 2025, a decrease of -12.95%. This brings the company's revenue in the last twelve months to $6.30M, down -2.97% year-over-year. In the fiscal year ending March 31, 2025, Encision had annual revenue of $6.56M, down -0.46%.
Revenue (ttm)
6.30M
Revenue Growth
-2.97%
P/S Ratio
0.67
Revenue / Employee
273.90K
Employees
24
Market Cap
4.20M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 6.56M | -30.57K | -0.46% |
| Mar 31, 2024 | 6.59M | -762.63K | -10.38% |
| Mar 31, 2023 | 7.35M | -320.12K | -4.17% |
| Mar 31, 2022 | 7.67M | 130.80K | 1.74% |
| Mar 31, 2021 | 7.54M | -132.37K | -1.73% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Elite Pharmaceuticals | 122.89M |
| Glass House Brands | 196.17M |
| American Oncology Network | 1.76B |
| Northwest Biotherapeutics | 937.00K |
| Silence Therapeutics | 25.83M |
| Global Cord Blood | 196.10M |
| Zomedica | 29.45M |
Encision News
- 23 days ago - Encision GAAP EPS of -$0.02, revenue of $1.53M - Seeking Alpha
- 23 days ago - Encision Reports Second Quarter Fiscal Year 2026 Results - Accesswire
- 3 months ago - Encision Completes $500,000 Private Placement - Accesswire
- 4 months ago - Encision GAAP EPS of $0.00, revenue of $1.49M - Seeking Alpha
- 4 months ago - Encision Reports First Quarter Fiscal Year 2026 Results - Accesswire
- 5 months ago - Encision GAAP EPS of $0.00, revenue of $1.52M - Seeking Alpha
- 5 months ago - Encision Reports Fourth Quarter Fiscal Year 2025 Results - Accesswire
- 10 months ago - Encision GAAP EPS of $0.00, revenue of $1.46M - Seeking Alpha